Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls.
Journal: Frontiers in immunology
Published: June 15, 2022
Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions.
Journal: Journal of cellular and molecular medicine
Published: August 22, 2021
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation.
Journal: Blood advances
Published: April 05, 2021
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin.
Journal: Oncogene
Published: August 06, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: November 25, 2018
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival.
Journal: Bone marrow transplantation
Published: November 20, 2018
Rare Variant Quantitation Using Droplet Digital PCR.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 24, 2018
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.
Journal: Blood
Published: November 09, 2017
The rocky road to personalized medicine in acute myeloid leukaemia.
Journal: Journal of cellular and molecular medicine
Published: May 31, 2017
Last Updated: 09/26/2026